YLYing Li

Ying Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ying Li has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Editorial: Luminescent Nanomaterials in Translational Medicine

    by Benzhong Tang, Yan Yan, Lingming Zhang, Wenfu Zheng, Gang Chen, Ying Li

    Editorial: Luminescent Nanomaterials in Translational Medicine

  • Open Access

    Precise Molecular Engineering of Type I Photosensitizers with Near‐Infrared Aggregation‐Induced Emission for Image‐Guided Photodynamic Killing of Multidrug‐Resistant Bacteria

    by Peihong Xiao, Zipeng Shen, Deliang Wang, Yinzhen Pan, Ying Li, Junyi Gong, Lei Wang, Dong Wang, Ben Zhong Tang

    Multidrug resistance (MDR) bacteria pose a serious threat to human health. The development of alternative treatment modalities and therapeutic agents for treating MDR bacteria‐caused infections remains a global challenge. Herein, a series of near‐infrared (NIR) anion–π+ photosensitizers featuring aggregation‐induced emission (AIE‐PSs) are rationally designed and successfully developed for broad‐spectrum MDR bacteria eradication. Due to the strong intramolecular charge transfer (ICT) and enhanced highly efficient intersystem crossing (ISC), these electron‐rich anion–π+ AIE‐PSs show boosted type I reactive oxygen species (ROS) generation capability involving hydroxyl radicals and superoxide anion radicals, and up to 99% photodynamic killing efficacy is achieved for both Methicillin‐resistant Staphylococcus aureus (MRSA) and multidrug resistant Escherichia coli (MDR E. coli) under a low dose white light irradiation (16 mW cm−2). In vivo experiments confirm that one of these AIE‐PSs exhibit excellent therapeutic performance in curing MRSA or MDR E. coli‐infected wounds with negligible side‐effects. The study would thus provide useful guidance for the rational design of high‐performance type I AIE‐PSs to overcome antibiotic resistance.


  • Side Area‐Assisted 3D Evaporator with Antibiofouling Function for Ultra‐Efficient Solar Steam Generation

    by Haoxuan Li, Wei Zhu, Meng Li, Ying Li, Ryan T. K. Kwok, Jacky W. Y. Lam, Lei Wang, Dong Wang, Ben Zhong Tang

    Solar‐driven interfacial steam generation (SISG) has been recognized as a promising strategy to solve water shortages in an eco‐friendly and low‐cost way. However, the practical application of SISG is vitally restricted by some inherent limits, especially for finite evaporation rate and insufficient working life of evaporator. Herein, a novel SISG system involving an all‐fiber porous cylinder‐like foam 3D evaporator, side area‐assisted evaporation protocol, and aggregation‐induced‐emission‐active solar absorber with “one stone two birds” function is explored. The solar absorber exhibits efficient photothermal conversion, endowing the side area‐assisted evaporator with as high as 3.6 kg m−2 h−1 of solar evaporation rate, which is highly desirable for SISG under 1 sun of irradiation. Moreover, the solar absorber is capable of powerfully producing reactive oxygen species upon sunlight irradiation, which results in extraordinary photodynamic killing of bacteria nearby the fiber to prevent biofouling, consequently improving the working life of evaporator.


  • Open Access

    Hypoxia-activated probe for NIR fluorescence and photoacoustic dual-mode tumor imaging

    by Meng Li, Huan Li, Qian Wu, Niu Niu, Jiachang Huang, Lingmin Zhang, Ying Li, Dong Wang, Ben Zhong Tang


  • Open Access

    Bright AIE Nanoparticles for Two-Photon Imaging and Localized Compound Therapy of Cancers.pdf

    by Ying Li, Rongbing Tang, Xiaoyan Liu, Junyi Gong, Zujin Zhao, Zonghai Sheng, Jiangjiang Zhang, Xuanyu Li, Guangle Niu, Ryan Tsz Kin Kwok, et al.

    Photodynamic therapy (PDT) is a non-invasive therapeutic strategy for cancer treatment but it always suffers from low reactive oxygen species (ROS) efficiency generated from traditional organic dyes owing to weak absorption in the optical transparent window of biological tissues and fluorescence quenching at a concentrated solution or in nanoparticles. Herein, we present cationic lipid-encapsulated aggregation-induced emission (AIE) nanoparticles (NPs) that have a high quantum yield (23%) and a maximum two-photon absorption (TPA) cross-section of 560 GM irradiated by near infrared light (800 nm). The AIE NPs can serve as imaging agents for spatiotemporal imaging of tumor tissues with a penetration depth up to 505 µm on mice melanoma model. Noteworthy, the AIE NPs can efficiently generate singlet oxygen (1O2) and highly toxic hydroxyl radicals (·OH) upon 800 nm-light irradiation for photodynamic tumor ablation. In addition, the AIE NPs can be effectively cleared from the mouse body after the imaging and therapy. This study provides a new strategy to develop theranostic agent for cancer image-guided PDT with high brightness, superior photostability and high biosafety

  • Open Access

    Efficient Killing of Multidrug-Resistant Intracellular Bacteria by AIEgens in Vivo

    by Ying Li, Fei Liu, Jiangjiang Zhang, Xiaoye Liu, Peihong Xiao, Haotian Bai, Shang Chen, Dong Wang, Simon H. P. Sung, Ryan Tsz Kin Kwok, et al.

    Bacteria infected cells acting as “Trojan horses” not only protect bacteria from antibiotic therapies and immune clearance, but also increase the dissemination of pathogens from the initial sites of infection. Antibiotics are hard and insufficient to treat such hidden intracellular bacteria, especially the multidrug-resistant (MDR) bacteria. Herein, aggregation-induced emission luminogens (AIEgens) such as TBPs showed potent broad-spectrum bactericidal activity against both extracellular and intracellular Gram-positive pathogens at low-dose levels. TBPs triggered reactive oxygen species (ROS)-mediated membrane damage to kill bacteria, regardless of light irradiation. Additionally, such AIEgens activated mitochondria dependent autophagy to eliminate intracellular bacteria in host cells. Compared to the routinely used vancomycin in clinics, TBPs showed comparable efficacy against methicillin-resistant Staphylococcus aureus (MRSA) in vivo. Our studies demonstrate that AIEgens are promising new agents for the treatment of MDR bacteria associated infections.

  • Killing G(+) or G(−) Bacteria? The Important Role of Molecular Charge in AIE‐Active Photosensitizers

    by Xiujuan Shi, Simon H. P. Sung, Joe H. C. Chau, Ying Li, Zhiyang Liu, Ryan T. K. Kwok, Junkai Liu, Peihong Xiao, Jiangjiang Zhang, Bin Liu, et al.

    Bacterial infections pose a serious threat to human health. Photodynamic therapy is an effective medical treatment to solve the problems raised by antibiotic resistant bacteria. But it is not easy to have photosensitizers (PSs) that can simultaneously produce efficient fluorescence and reactive oxygen species. Traditional PSs show compromised performances due to the aggregation‐caused quenching effect in aqueous media, however, luminogens with aggregation‐induced emission (AIE) can inherently achieve high fluorescence and efficient ROS generation. In addition, electrostatic interaction is generally accepted to be responsible for initial targeting of bacteria. But for AIE PSs, the roles of molecular charges on antibacterial efficiency are rarely considered. Herein, two red‐emissive AIE PSs with the same luminogenic core but carrying different number of positive charges are designed, and their antibacterial performance and the killing mechanism toward Gram‐positive (G(+)) and Gram‐negative (G(−)) bacteria are investigated. The AIE PSs with highly efficient singlet oxygen generation can clearly image and selectively kill bacteria over mammalian cells. With the increase in the positive charges of AIE PSs, the improvement in antibacterial efficiency is great against G(−) bacteria, but it is negligible against G(+) bacteria. This research will provide new insight into the rational design of new antibacterial materials.